2026-01-27 - Analysis Report
**Company Overview**
Salesforce is a customer relationship management (CRM) company that provides cloud-based software solutions for sales, marketing, and customer service.

**Return Rate Comparison**
* Cumulative return of review stock (CRM): 53.97%
* Cumulative return of comparison stock (S&P 500, VOO): 127.58%
* Divergence (degree of divergence): -73.30
* Relative divergence: 1.60%

The cumulative return of CRM is significantly lower than that of the S&P 500, indicating a divergence of -73.30. However, the relative divergence of 1.60% suggests that this divergence is relatively common in past data.

**Historical Performance Analysis**
| Year | CAGR | MDD | Alpha | Beta | Capitalization (B$) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 49.0% | 22.9% | 40.0% | 1.4 | 130.4B |
| 2017-2019 | 54.0% | 22.9% | 29.0% | 1.4 | 154.8B |
| 2018-2020 | 57.0% | 34.8% | 33.0% | 1.1 | 211.8B |
| 2019-2021 | 39.0% | 34.8% | -25.0% | 1.1 | 241.9B |
| 2020-2022 | -77.0% | 53.0% | -82.0% | 1.2 | 126.2B |
| 2021-2023 | -8.0% | 53.0% | -26.0% | 1.4 | 250.5B |
| 2022-2024 | 47.0% | 38.7% | 18.0% | 1.4 | 318.3B |
| 2023-2025 | 49.0% | 35.4% | -26.0% | 1.2 | 252.2B |

CRM's historical performance shows varying results, with high growth rates in some periods and significant losses in others.

**Recent Stock Price Fluctuations**
| Moving Average | Value |
| --- | --- |
| 5-day SMA | $225.44 |
| 20-day SMA | $247.52 |
| 60-day SMA | $247.59 |
* Close: $229.40
* Recent market change: 0.59

The 20-day and 60-day SMAs are currently above the close price, while the 5-day SMA is below. This indicates a possible short-term decrease in stock price.

**Indicators and Delta Analysis**
Market Risk Indicator (MRI): 0.70 (High Investment Not Recommended)
* RSI: 29.44
* PPO: -1.25
* Hybrid Signal: Buy (Cash 0%)
* Recent (20 days) relative divergence change: 1.30 (+): improving
* 7-day Rank change: 54 (+): rank up
* 7-day Dynamic Expected Return change: 5078.20 (+): improving

The MRI suggests a medium investment risk, while the RSI and PPO indicators show a bearish trend. However, the hybrid signal suggests a buy, and the recent changes in relative divergence and expected return are positive.

**Expected Return**
Expected Return (%): 98.20%

**Recent News & Significant Events**
* [2026-01-21] What Is Spooking CRM Stock Investors? - Forbes (link)
* [2026-01-26] CRM Stock Is Flashing A Warning Signal: Salesforce's Operational 'Quality' Remains High, But Price Trends Turn Triple Red - Benzinga (link)
* [2026-01-02] Salesforce (CRM) Stock Trades Down, Here Is Why - Yahoo Finance (link)
* [2026-01-26] Salesforce: Lower Growth Outlook But Extremely Undervalued (NYSE:CRM) - Seeking Alpha (link)
* [2026-01-22] Is Salesforce Stock At A Key Buying Opportunity? - Forbes (link)
* [2026-01-14] Is Salesforce Stock A Buy After Recent Decline? - Trefis (link)

These news articles discuss the recent decline in CRM stock price and the company's operational quality.

**Analyst Opinions**
Analyst Consensus:
* Key: Buy
* Mean (1=StrongBuy~5=Sell): 1.64 (~Buy)
* Opinions: 53
* Target Price (avg/high/low): 329.65 / 475.00 / 223.00

Most analysts recommend a buy, with a target price range of 329.65-475.00.

**Recent Earnings Analysis**
| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-12-04 | 2.2 | 10.26 B$ |
| 2025-09-04 | 1.97 | 10.24 B$ |
| 2025-05-29 | 1.61 | 9.83 B$ |
| 2024-12-04 | 1.6 | 9.44 B$ |
| 2025-12-04 | 1.6 | 9.44 B$ |

CRM's earnings per share (EPS) and revenue have been steadily increasing in the past few quarters, with a slight decrease in the last quarter.

**Financial Information**
**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-10-31 | $10.26B | 78.02% |
| 2025-07-31 | $10.24B | 78.10% |
| 2025-04-30 | $9.83B | 76.96% |
| 2025-01-31 | $9.99B | 77.81% |
| 2024-10-31 | $9.44B | 77.71% |

**Capital and Profitability**
| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-10-31 | $60.02B | 3.48% |
| 2025-07-31 | $61.33B | 3.08% |
| 2025-04-30 | $60.67B | 2.54% |
| 2025-01-31 | $61.17B | 2.79% |
| 2024-10-31 | $58.52B | 2.61% |

CRM's revenue and profit margin have been increasing in the past few quarters, while its equity and return on equity (ROE) have fluctuated.

**Comprehensive Analysis**
CRM's historical performance shows varying results, with high growth rates in some periods and significant losses in others. The recent stock price fluctuations indicate a possible short-term decrease. The indicators suggest a bearish trend, but the hybrid signal suggests a buy, and the recent changes in relative divergence and expected return are positive. The analyst opinions are generally bullish, with a target price range of 329.65-475.00. The earnings analysis shows steadily increasing EPS and revenue, and the financial information indicates increasing revenue and profit margin, while equity and ROE have fluctuated.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.